Skip to main content
. 2014 Mar 28;171(8):1973–1987. doi: 10.1111/bph.12431

Figure 3.

Figure 3

BH3 mimetics (1). (A) Pan-selective BCL-2 inhibitor GX15-070/obatoclax; (B) pan-selective BCL-2 inhibitor AT-101/(−)-Gossypol; (C) pan-selective BCL-2 inhibitor BI-97C1/sabutoclax; (D) BCL-XL, BCL-2 and BCL-W inhibitor ABT-737; (E) BCL-XL, BCL-2 and BCL-W inhibitor ABT-263/navitoclax; (F) BCL-XL and BCL-2 inhibitor derived from ABT-737.